Screener
NRX Pharmaceuticals, Inc. NRXP Q1 2025 Annual earnings
Reported May 15, 2025 · After market close
Revenue$2.3M
EPS-$0.34Miss by $0.04
EPS estimate-$0.30
Next report
Nov 13, 2026 (in 2 months)Revenue estimate$1.3M
EPS estimate-$0.26
Versus estimates
Revenue
Diluted EPS
FAQ
- When did NRX Pharmaceuticals, Inc. report Q1 2025 earnings?
- NRX Pharmaceuticals, Inc. (NRXP) reported Q1 2025 earnings on May 15, 2025 after market close.
- What were NRX Pharmaceuticals, Inc.'s Q1 2025 revenue and EPS?
- NRX Pharmaceuticals, Inc. reported revenue of $2.3M and eps of $-0.34 for Q1 2025.
- Did NRX Pharmaceuticals, Inc. beat estimates in Q1 2025?
- EPS missed the consensus estimate of $-0.30 by $0.04.
- How did NRX Pharmaceuticals, Inc.'s Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 54.1% from $-0.74.
- Where can I find NRX Pharmaceuticals, Inc.'s Q1 2025 SEC filings?
- You can read the 8-K earnings release (0001437749-25-016272) and the 10-K/A periodic report (0001437749-25-013874) directly on SEC EDGAR. The filing index links above go to sec.gov.
